Genmab A/S Files 6-K, Incorporates into S-8 Filings
Ticker: GNMSF · Form: 6-K · Filed: Sep 10, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Sep 10, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, corporate-governance, registration-statement
TL;DR
Genmab filed a 6-K on 9/10/25, updating its S-8 filings with its Articles of Association.
AI Summary
Genmab A/S filed a Form 6-K on September 10, 2025, to report updates. This filing is incorporated by reference into several of Genmab's existing S-8 registration statements, including File No. 333-284876. The report includes their Articles of Association as Exhibit 3.1.
Why It Matters
This filing ensures that Genmab's registration statements remain current by incorporating updated information, which is crucial for ongoing stock-based compensation plans.
Risk Assessment
Risk Level: low — This is a routine administrative filing that incorporates existing documents and does not present new financial or operational risks.
Key Players & Entities
- Genmab A/S (company) — Registrant
- September 10, 2025 (date) — Filing Date
- Form 6-K (document) — Filing Type
- Form S-8 (document) — Incorporated Registration Statement
- File No. 333-284876 (document) — Specific S-8 Registration Statement
- Articles of Association (document) — Exhibit
FAQ
What is the purpose of this Form 6-K filing by Genmab A/S?
The purpose of this Form 6-K filing is to report updates and to be incorporated by reference into Genmab A/S's existing registration statements on Form S-8.
When was this Form 6-K filed by Genmab A/S?
This Form 6-K was filed on September 10, 2025.
Which registration statements does this 6-K filing get incorporated into?
This 6-K filing is incorporated into Genmab A/S's registration statements on Form S-8, specifically mentioning File Nos. 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
What specific document is included as an exhibit in this filing?
The filing includes the Articles of Association of Genmab A/S as Exhibit 3.1.
What is the primary business of Genmab A/S?
Genmab A/S is classified under the Standard Industrial Classification code 2834, which pertains to Pharmaceutical Preparations.
Filing Stats: 211 words · 1 min read · ~1 pages · Grade level 14.2 · Accepted 2025-09-10 12:01:55
Filing Documents
- gmab_20250910xaoa6kx.htm (6-K) — 13KB
- gmab_20250910xex3d1.htm (EX-3.1) — 223KB
- 0001434265-25-000076.txt ( ) — 236KB
From the Filing
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF SEPTEMBER 2025 COMMISSION FILE NUMBER 001-38976 Genmab AS (Exact name of Registrant as specified in its charter) Carl Jacobsens Vej 30 2500 Valby Denmark +45 70 20 27 28 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F This report on Form 6-K shall be deemed to be incorporated by reference in Genmab AS's registration statements on Form S-8 (File No. 333-232693, 333-253519, 333-262970, 333-277273 and 333-284876 ) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. EXHIBIT INDEX Exhibit Description of Exhibit 3.1 Articles of Association SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GENMAB AS BY s Anthony Pagano Name Anthony Pagano Title Executive Vice President Chief Financial Officer DATE September 10, 2025